Product information
CagriSema is a combination of cagrilintide and semaglutide administered via subcutaneous injection. It is a potent weight-loss medication that achieves weight reduction by combining the distinct mechanisms of action of these two agents.
CagriSema (2.5mg+2.5mg)
Specifications
- Product
- CagriSema (2.5mg+2.5mg)
- Content
- 5mg per vial
- SKU
- CS5
Batch testing & COA
Batch-specific results are provided for each product.
Related compounds
5-Amino-1MQ 5mg
NNMT inhibition, lipid metabolism, energy expenditure, NAD+ metabolism, insulin sensitivity, abdominal fat management, and body shaping.
5-Amino-1MQ 10mg
NNMT inhibition, lipid metabolism, energy expenditure, NAD+ metabolism, insulin sensitivity, abdominal fat management, and body shaping.
5-Amino-1MQ 20mg
NNMT inhibition, lipid metabolism, energy expenditure, NAD+ metabolism, insulin sensitivity, abdominal fat management, and body shaping.
5-Amino-1MQ 50mg
NNMT inhibition, lipid metabolism, energy expenditure, NAD+ metabolism, insulin sensitivity, abdominal fat management, and body shaping.